About Manne Laboratories Private Limited
Data last updated:
Manne Laboratories Private Limited was a private limited company based in Visakhapatnam, Andhra Pradesh, India, operated as a subsidiary of Ra Chem Pharma Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 March 2014.
The company was registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24100AP2014PTC093610. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹13 Cr and a paid-up capital of ₹12.95 Cr. It was led by directors including Ravi Kumar Yerra (Whole-Time Director) and Sirish Kumar Ravula.
Its last annual general meeting (AGM) was held on 27 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office was at Plot No. 27C Apsez Gurujapalem Rambili Mandal Atchutapuram, Visakhapatnam, Andhra Pradesh, India – 531011.
As per the financials filed for FY 2019, the company reported a revenue of ₹14.37 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹67.83 Lakh (net margin -471.9%) and EBITDA of -₹29.6 Lakh (EBITDA margin -205.9%).
As per MCA filings, the company had satisfied charges of ₹11.7 Cr on record. The company has 7 deals on record (3 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹7.43 Cr; the latest was in September 2018. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Comed Bio-Tech Private Limited with revenue of ₹29,339.
The last known website on record is rachempharma.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No. 27C Apsez Gurujapalem Rambili Mandal Atchutapuram, Visakhapatnam, Andhra Pradesh, India – 531011
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Manne Laboratories Private Limited
The main business activity of Manne Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Manne Laboratories Private Limited FY 2019 filings available
Manne Laboratories Private Limited reported revenue of ₹14.37 Lakh (up 1600% YoY) for FY 2019.
Financial Statement Summary of Manne Laboratories Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹14.37 Lakh | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹29.6 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹67.83 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Manne Laboratories Private Limited
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -205.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -471.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Manne Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Manne Laboratories Private Limited
Manne Laboratories has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sirish Kumar Ravula Also directs: Devi Pharmatech Private Limited, Epione Labs Private Limited, Agil Seismic Services Private Limited and 3 more | Director | 21 Nov 2018 | 7 Years 10 Months | As last reported |
| Yogesh Shenoy Krishna | Director | 13 Dec 2018 | 7 Years 10 Months | As last reported |
| Ravi Kumar Yerra Also directs: Devi Pharmatech Private Limited | Whole-Time Director | 28 Aug 2018 | 8 Years 1 Months | As last reported |
Peer Comparison of Manne Laboratories Private Limited
Manne Laboratories Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Manne Laboratories Private Limited this company | ₹14.37 Lakh (FY 2019) | •••• | •••• | 1600.0% | •••• | Visakhapatnam, Andhra Pradesh, India |
| Comed Bio-Tech Private Limited | ₹29,339 (FY 2025) | •••• | •••• | -23.0% | •••• | Vadodara, Gujarat, India |
| Sr Products Private Limited | ₹29,136 (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Udsav Healthcare Services Private Limited | ₹28,900 (FY 2023) | •••• | •••• | -86.0% | •••• | Chennai, Tamil Nadu, India |
| Mediways Distributors Private Limited | ₹28,500 (FY 2025) | •••• | •••• | 39.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Krti Lifescience Limited | ₹27,600 (FY 2024) | •••• | •••• | -43.0% | •••• | Thrissur, Kerala, India |
| Nikam Industries Private Limited | ₹27,300 (FY 2025) | •••• | •••• | •••• | Mahad, Maharashtra, India | |
| Silicon Scientific Private Limited | ₹27,285 (FY 2024) | •••• | •••• | •••• | Bangalore, Karnataka, India | |
| Dupha Formulations (India) Private Limited | ₹27,000 (FY 2019) | •••• | •••• | •••• | Ujjain, Madhya Pradesh, India | |
| Lyotex Lifesciences Private Limited | ₹26,940 (FY 2024) | •••• | •••• | •••• | Thane, Maharashtra, India | |
| Innovera Pharmaceuticals Private Limited | ₹26,861 (FY 2025) | •••• | •••• | -5.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Manne Laboratories by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Manne Laboratories Private Limited
Manne Laboratories Private Limited is audited by C VENKAT KRISHNA & CO for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| C VENKAT KRISHNA & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Manne Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Manne Laboratories Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Oct 2015 | Andhra Bank | ₹11.7 Cr | Satisfied |
Total charge records: 1 View all charges
Deals & Funding of Manne Laboratories Private Limited
Manne Laboratories Private Limited has 7 deals on record (3 funding rounds, 2 rights issues, 2 secondary share transfers), with disclosed funding of ₹7.43 Cr; the latest was in September 2018.
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2018 | Secondary share transfer | Undisclosed | Buyer: Ra Chem Pharma Limited , RA Chem Pharma Limited & Ravula Sirish Kumar Seller: Siri Green Infratech Private Limited , 3 individuals |
| Dec 2017 | Secondary share transfer | Undisclosed | Buyer: Ra Chem Pharma Limited Seller: an individual |
| Jun 2017 | Funding round | ₹1.73 Cr | Investors: Siri Green Infratech Private Limited , 3 individuals |
| Mar 2017 | Rights issue | ₹1.22 Cr | Investors: 4 individuals |
| Jan 2017 | Funding round | ₹2.77 Cr | Investors: 4 individuals |
Full deal history
All 7 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Manne Laboratories Private Limited
Employment history and EPFO contributions of people linked to Manne Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Manne Laboratories Private Limited
Manne Laboratories Private Limited has 8 board changes on record since 2018: 3 appointments and 5 cessations. The latest: Sirish Kumar Ravula ceased to be Additional Director on 28 Dec 2018.
2 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Manne Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Manne Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Manne Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Manne Laboratories Private Limited
Manne Laboratories has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Manne Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Manne Laboratories Private Limited
Frequently Asked Questions about Manne Laboratories Private Limited
Manne Laboratories has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Manne Laboratories was a private limited company based in Visakhapatnam, Andhra Pradesh, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 19 March 2014 and is registered under CIN U24100AP2014PTC093610. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Manne Laboratories was incorporated on 19 March 2014. It is registered with the Registrar of Companies, Vijayawada.
Manne Laboratories had 3 directors:
- Ravi Kumar Yerra - Whole-Time Director
- Sirish Kumar Ravula - Director
- Yogesh Shenoy Krishna - Director
The CIN (Corporate Identification Number) of Manne Laboratories is U24100AP2014PTC093610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Manne Laboratories is at Plot No. 27C Apsez Gurujapalem Rambili Mandal Atchutapuram, Visakhapatnam, Andhra Pradesh, India – 531011.
Manne Laboratories can be reached through the website rachempharma.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
Manne Laboratories reported revenue of ₹14.37 Lakh for FY 2019 (up 1600% YoY).
Manne Laboratories has an authorised share capital of ₹13 Cr and a paid-up capital of ₹12.95 Cr.
Manne Laboratories reported a net loss of ₹67.83 Lakh (net margin -471.9%) and EBITDA of -₹29.6 Lakh (EBITDA margin -205.9%) for FY 2019, as per its filed financial statements.
No. Manne Laboratories has 1 GST registration on record and it is cancelled or inactive.